DOI: 10.3390/ijms27167410 ISSN: 1422-0067
Comment on Yamazaki et al. Long-Term Effects of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Predictors of Treatment Response and Safety over 6 Years of Continuous Therapy. Int. J. Mol. Sci. 2024, 25, 2088
Liliana Italia De Rosa, Martina Catania, Kristiana Kola, Giuseppe Vezzoli, Matteo Brambilla Pisoni, Sara Farinone, Paolo Manunta, Maria Teresa Sciarrone AlibrandiIn response to the article [...]